Skip to main content
Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · IEX Real-Time Price · USD
81.83
+1.31 (1.63%)
At close: May 31, 2024, 4:00 PM
82.50
+0.67 (0.82%)
After-hours: May 31, 2024, 7:49 PM EDT

Lantheus Holdings Revenue

Lantheus Holdings had revenue of $1.37B in the twelve months ending March 31, 2024, with 32.98% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $369.98M with 23.00% year-over-year growth. In the year 2023, Lantheus Holdings had annual revenue of $1.30B with 38.65% growth.

Revenue (ttm)
$1.37B
Revenue Growth
+32.98%
P/S Ratio
4.15
Revenue / Employee
$1,637,434
Employees
834
Market Cap
5.67B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.30B361.37M38.65%
Dec 31, 2022935.06M509.85M119.91%
Dec 31, 2021425.21M85.80M25.28%
Dec 31, 2020339.41M-7.93M-2.28%
Dec 31, 2019347.34M3.96M1.15%
Dec 31, 2018343.37M12.00M3.62%
Dec 31, 2017331.38M29.53M9.78%
Dec 31, 2016301.85M8.39M2.86%
Dec 31, 2015293.46M-8.14M-2.70%
Dec 31, 2014301.60M17.93M6.32%
Dec 31, 2013283.67M-4.43M-1.54%
Dec 31, 2012288.11M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.32B
Organon & Co. 6.35B
DENTSPLY SIRONA 3.94B
Exelixis 1.85B
Stevanato Group 1.18B
Halozyme Therapeutics 862.99M
Ionis Pharmaceuticals 776.62M
Glaukos 326.43M
Revenue Rankings

LNTH News

More News